Image

Global Flourescent In Situ Hybridization (FISH) Probe Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • May 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • May 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Flourescent In Situ Hybridization (FISH) Probe Market, By Technology (FISH, CISH, DISH), Type (DNA, RNA), Application (Cancer Research, Genetic Diseases, Other), End-User (Research, Clinical, Companion Diagnostics) - Industry Trends and Forecast to 2029

Flourescent In Situ Hybridization (FISH) Probe Market

Market Analysis and Size

DNA probe-based diagnostics is gaining popularity for determining suspected disorders caused by infections or germs in medical diagnostics. In addition, the identification of new areas for diagnostic markets increased automation of diagnostic tests, and investments in pharmacogenomics and pharmaceutical research are all driving the market forward. The rising prevalence of genetic disorders such as Acute Lymphoblastic Leukemia (ALL) further drives the market growth.

Data Bridge Market Research analyses that the flourescent in situ hybridization probe market which was USD 713.2 million in 2021, would rocket up to USD 1189.24 million by 2029, and is expected to undergo a CAGR of 6.6% during the forecast period. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Fluorescent in situ hybridization (FISH) probe is a sub-atomic cytogenetic technique that visualizes genetic components using fluorescent probes. These probes are molecules that absorb a specific wavelength of light and then emit light when they bind to a particular DNA/RNA sequence. They are used to detect structural and numerical anomalies in chromosomes and monitor therapeutic drugs and diagnose rare genetic illnesses.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

 By Technology (FISH, CISH, DISH), Type (DNA, RNA), Application (Cancer Research, Genetic Diseases, Other), End-User (Research, Clinical, Companion Diagnostics)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Abnova Corporation (U.S), Agilent Technologies Inc.(U.S), Biocare Medical LLC (U.S), LGC Biosearch Technologies (U.S), Creative BioLabs (US), F. Hoffmann-La Roche Ltd.(Switzerland), Genemed Biotechnologies Inc. (U.S), Merck KGaA (Germany), Oxford Gene Technology IP Limited (U.K), PerkinElmer Inc.(U.S), QIAGEN (Germany), BioDot (U.S), Bio-Techne (U.S), BioGenex (U.S), PerkinElmer Inc. (U.S)

Market Opportunities

  • Increasing awareness among people regarding early diagnosis of genetic disorders
  • Growing disposable income

Flourescent In Situ Hybridization (FISH) Probe Market Dynamics

Drivers

  • Rising occurrence of diseases having the cytogenetic base

The adoption of FISH probe techniques is expected to increase due to genetic abnormalities and cancer and the requirement for speedy, sensitive, and accurate prognostic procedures for disease validation over the forecast period 2022-2029.

  • Increasing R&D initiatives

The expansion of the Fluorescent In Situ Hybridization (FISH) probe market can be described to the discovery of novel disease-specific biomarkers and pipeline products awaiting regulatory approval. The market is likely to be driven further by rising awareness, rising healthcare expenditure, and the development of novel probes.

  • Increasing occurrence of various genetic and chronic disorders

Growing demand for In Vitro Diagnostics (IVD) testing and targeted medicines around the world is also propelling the industry forward. In contrast to traditional cytogenetic (cell gene) examinations, FISH testing can detect minute genetic changes that are generally undetectable under the microscope. As a result, these probes are frequently employed in cancer and genetic condition detection, prediction, and clinical care.

Opportunities

Furthermore, the use of these tests in various diseases like as cancer and genetic disorders is rising in this region, which is expected to drive demand even higher. The market's growth can be described to rising public awareness about the early detection of genetic abnormalities, rising disposable income, and a well-established R&D infrastructure. Government reforms and favorable reimbursement procedures are expected to propel the business forward.

Restraints/Challenges

Virtual karyotyping is a low-cost, clinically available alternative to FISH panels that uses thousands to millions of probes on a single array to identify copy number variations at unprecedented resolution across the genome. The development of alternative techniques is hampering the growth of the market. Furthermore, there are high financial costs associated with the fish probe, as well as variations in regulations for the development and use of these probes based on different regions, as well as a lack of skilled professionals to interact with and utilize this technology from various underdeveloped regions, all of these factors are expected to limit the market's growth.

This flourescent in situ hybridization market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the flourescent in situ hybridization market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Flourescent In Situ Hybridization (FISH) Probe Market

The positive stranded SARS-CoV-2 RNA virus causes COVID-19 (Coronavirus Disease 2019) in humans and is closely related to bat-derived severe acute respiratory syndrome-like coronaviruses. SARS-CoV-2 is the human virus that most closely resembles the SARS-CoV and MERS-CoV viruses, which cause severe acute respiratory syndrome and Middle Eastern respiratory syndrome. The RNAscope technology's unrivalled sensitivity and specificity allow direct imaging of the virus and estimation of viral load in any tissue and cell with morphological context. This method avoids the requirement for expensive and time-consuming antibody creation for newly discovered gene targets or diseases like the COVID-19 SARS-CoV-2 virus.

Recent Development

 Applied Spectral Imaging, a provider of biomedical imaging analysis solutions, released a new upgraded product for the fluorescence in situ hybridization market in January 2019. The new product, which includes improved hardware components, can do fluorescence in situ hybridization (FISH) imaging quickly.

Global Flourescent In Situ Hybridization (FISH) Probe Market Scope

The flourescent in situ hybridization market is segmented on the basis of type, technology, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology 

  •  Flow FISH

    • Q FISH
    • Other FISH

Type 

  • DNA
  • RNA

    • mRNA
    • miRNA
    • Other

Application 

  • Cancer Research

    • Lung
    • Breast
    • Bladder
    • Hematological
    • Gastric
    • Prostrate
    • Cervical
    • Other

  • Genetic Diseases
  • Other

End-User

  • Research
  • Clinical
  • Companion diagnostics

Flourescent In Situ Hybridization Market Regional Analysis/Insights

The flourescent in situ hybridization (FISH) probe market is analyzed and market size insights and trends are provided by country, type, technology, application and end-user as referenced above.

The countries covered in the flourescent in situ hybridization (FISH) probe market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

  • In 2018, North America had the highest revenue share. Some of the variables related to the expansion include a high incidence rate of genetic abnormalities leading to birth deformities, developmental impairments, and other metabolic syndromes. 

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rising prevalence of diseases having the cytogenetic base and growing R&D initiatives.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The flourescent in situ hybridization (FISH) probe market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for flourescent in situ hybridization market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the flourescent in situ hybridization market. The data is available for historic period 2010-2020.

Competitive Landscape and Flourescent In Situ Hybridization Market Share Analysis

The flourescent in situ hybridization (FISH) probe market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to flourescent in situ hybridization (FISH) probe market.

Some of the major players operating in the flourescent in situ hybridization (FISH) probe market are:

  • Abnova Corporation (U.S)
  • Agilent Technologies Inc.(U.S)
  • Biocare Medical LLC (U.S)
  • LGC Biosearch Technologies (U.S)
  • Creative BioLabs (US)
  • F. Hoffmann-La Roche Ltd.(Switzerland)
  • Genemed Biotechnologies Inc. (U.S)
  • Merck KGaA (Germany)
  • Oxford Gene Technology IP Limited (U.K)
  • PerkinElmer Inc.(U.S)
  • QIAGEN (Germany)
  • BioDot (U.S)
  • Bio-Techne (U.S)
  • BioGenex (U.S)
  • PerkinElmer Inc. (U.S)


SKU-

Why Choose Us


Frequently Asked Questions

The Flourescent in Situ Hybridization (FISH) Probe Market is expected USD 1189.24 million by 2029.
The Flourescent in Situ Hybridization (FISH) Probe Market is projected to grow at a CAGR of 6.6% during the forecast period of 2022-2029.
On the basis of application, the Flourescent in Situ Hybridization (FISH) Probe Market is segmented into Cancer Research, Genetic Diseases, Other.
On the basis of technology, the Flourescent in Situ Hybridization (FISH) Probe Market is segmented into FISH, CISH, DISH.